Neobio
PrivateLast Round
Strategic
Dec 28, 2020
Total Funding Raised
$16.15M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Neobio operates in Media, Entertainment & Gaming and is based in Shanghai. Its latest recorded funding round was a Strategic round in December 2020.
Neobio is a Chinese indoor entertainment company that operates high-end, large-scale family activity centers featuring play areas, bookstores, restaurants, and themed party rooms.
Sector
Media, Entertainment & Gaming
Verticals
Sports & Fitness, Home & Lifestyle
Business Model
B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neobio Comparables
Compare Neobio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| China New City Group Limited | 72% | |
| Alpha Group Co., Ltd. | 69% | |
| Hunan Palacemuse Culture Technology Co., Ltd. | 62% |
For institutional investors. Book with your work email.
Neobio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 28, 2020 | ||||
| Series B | Jun 5, 2019 | ||||
| Series A | Dec 12, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Neobio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tencent Exploration | Strategic |
| Day One Capital | Strategic |
| CMC Capital Partners | Series B |
| Dayone Capital | Strategic |
| Tencent Investment | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 28, 2026
Grew 19% QoQ from 21 to 25 employees.
- Aug 2, 2026
Grew 24% QoQ, from 21 to 26 employees.
For institutional investors. Book with your work email.
Neobio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neobio's valuation, stock price, and market status.
Is Neobio a public or private company?
Neobio is a private company.
What is the current stock price of Neobio?
Neobio is a private company, so its shares have no public market price. Caplight tracks Neobio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neobio worth (valuation)?
Valuation information for Neobio is not publicly available.
Can I buy Neobio stock?
Neobio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neobio's last funding round?
Neobio's most recent funding round was Strategic on December 28, 2020.
Who are the main investors in Neobio?
Key investors in Neobio include CMC Capital Partners.
Will Neobio IPO soon?
No public IPO plans have been announced for Neobio.
How can I track Neobio secondary market activity?
Caplight tracks bids, offers, and trades in Neobio's shares on secondary markets.